Literature DB >> 16635466

A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.

Phyllis C Leppert1, William H Catherino, James H Segars.   

Abstract

This article will discuss some recent insights based on our microarray studies that have emphasized the role the extracellular matrix, transforming growth factor beta, and collagen structure in fibroid formation. These studies led to appreciation of molecular similarities between fibroids and keloids. Collectively, these observations suggest a model of fibroid development based on an abnormal response to tissue repair, resulting in disordered healing and formation of an altered extracellular matrix.

Entities:  

Mesh:

Year:  2006        PMID: 16635466      PMCID: PMC4143906          DOI: 10.1016/j.ajog.2005.12.059

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  34 in total

Review 1.  Tissue repair, contraction, and the myofibroblast.

Authors:  Alexis Desmoulière; Christine Chaponnier; Giulio Gabbiani
Journal:  Wound Repair Regen       Date:  2005 Jan-Feb       Impact factor: 3.617

2.  The guinea pig model for uterine leiomyomata: gene-hormone interaction?

Authors:  John Tsibris
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

Review 3.  Uterine fibroids: the elephant in the room.

Authors:  Cheryl Lyn Walker; Elizabeth A Stewart
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

4.  The promise and perils of microarray analysis.

Authors:  William H Catherino; Phyllis C Leppert; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2006-04-27       Impact factor: 8.661

5.  Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.

Authors:  S N Iyer; G Gurujeyalakshmi; S N Giri
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

6.  Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen.

Authors:  K Kuroda; O Okamoto; H Shinkai
Journal:  J Invest Dermatol       Date:  1999-05       Impact factor: 8.551

7.  Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production.

Authors:  B S Lee; S B Margolin; R A Nowak
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

8.  Profiling of differentially expressed genes in human uterine leiomyomas.

Authors:  E-J Lee; G Kong; S-H Lee; S B Rho; C-S Park; B-G Kim; D-S Bae; J J Kavanagh; J-H Lee
Journal:  Int J Gynecol Cancer       Date:  2005 Jan-Feb       Impact factor: 3.437

9.  Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta.

Authors:  Xiaoping Luo; Li Ding; Jingxia Xu; Nasser Chegini
Journal:  Endocrinology       Date:  2004-12-16       Impact factor: 4.736

10.  Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium.

Authors:  Phyllis C Leppert; Thomas Baginski; Cara Prupas; William H Catherino; Susan Pletcher; James H Segars
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

View more
  71 in total

1.  Chlamydia trachomatis Seroprevalence and Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women.

Authors:  Kristen R Moore; Jennifer S Smith; Stephen R Cole; Dirk P Dittmer; Victor J Schoenbach; Donna D Baird
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

2.  Dysregulated chaperones associated with cell proliferation and negative apoptosis regulation in the uterine leiomyoma.

Authors:  Blendi Ura; Federica Scrimin; Giorgio Arrigoni; Michelangelo Aloisio; Lorenzo Monasta; Giuseppe Ricci
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

3.  Analysis of microarray experiments of gene expression profiling.

Authors:  Adi L Tarca; Roberto Romero; Sorin Draghici
Journal:  Am J Obstet Gynecol       Date:  2006-08       Impact factor: 8.661

4.  Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development.

Authors:  Mark Payson; Minnie Malik; Sarah Siti-Nur Morris; James H Segars; Rebecca Chason; William H Catherino
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

5.  Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women.

Authors:  Kristen R Moore; Stephen R Cole; Dirk P Dittmer; Victor J Schoenbach; Jennifer S Smith; Donna D Baird
Journal:  J Womens Health (Larchmt)       Date:  2015-04-22       Impact factor: 2.681

6.  Regulation of adipose oestrogen output by mechanical stress.

Authors:  Sagar Ghosh; Keith Ashcraft; Md Jamiul Jahid; Craig April; Cyrus M Ghajar; Jianhua Ruan; Howard Wang; Megan Foster; Daniel C Hughes; Amelie G Ramirez; Tim Huang; Jian-Bing Fan; Yanfen Hu; Rong Li
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.

Authors:  Erica E Marsh; Zhihong Lin; Ping Yin; Magdy Milad; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2007-09-04       Impact factor: 7.329

Review 8.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

9.  Vitamin d and the risk of uterine fibroids.

Authors:  Donna Day Baird; Michael C Hill; Joel M Schectman; Bruce W Hollis
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

10.  Cytokine patterns differ seasonally between women with and without uterine leiomyomata.

Authors:  Ganesa Wegienka; Donna Day Baird; Tracy Cooper; Kimberley J Woodcroft; Suzanne Havstad
Journal:  Am J Reprod Immunol       Date:  2013-04-25       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.